AI in Drug Discovery

AI in Drug Discovery

The drug development industry is bogged down by skyrocketing development costs and research that takes thousands of human hours. Putting each drug through clinical trials costs an estimated average of $1.3 billion, and only 10 percent of those drugs are successfully brought to market. Due to breakthroughs in technology, AI is speeding up this process by helping design drugs, predicting any side effects, identifying ideal candidates for clinical trials and potentially reducing costs by up to 50 percent.

Related Sessions